|
**Overview**: Oxalate 24-Hour Urine Panel**Introduction**: The Oxalate 24-Hour Urine Panel is a diagnostic tool designed to assess oxalate levels using timed urine collection. In India, hyperoxaluria contributes to ~20-30 percent of kidney stones (calcium oxalate predominant), with primary hyperoxaluria rare but severe (renal failure in childhood) and secondary forms common (high oxalate diet, enteric malabsorption). High morbidity from under-testing in rural/low-SES patients with recurrent flank pain or nephrolithiasis, limited metabolic labs, delayed dietary modification or pyridoxine leading to recurrent stones or CKD. Per urology practices aligned with ICMR and Urological Society of India guidelines, the test employs spectrophotometry for oxalate and total volume over 1-2 days with high accuracy, valuable for quantifying urinary oxalate excretion (>40-45 mg/24h abnormal). This diagnostic falls under renal screening and targets patients with recurrent calcium oxalate stones or family history, addressing accurate detection to guide low-oxalate diet, citrate supplementation, or genetic workup. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise oxalate assessment and reducing stone recurrence. Its 24-hour urine-based approach ensures reliable excretion quantification.**Other Names**: Oxalate 24H Pnl.**FDA Status**: FDA approved, CLIA certified for biochemistry/clinical pathology, compliant with 2025 standards.**Historical Milestone**: 24-hour urinary oxalate standard; in India, key in urolithiasis clinics.**Purpose**: The test assesses 2 parameters including oxalate to guide kidney stone assessment, quantify excretion, inform prevention.**Test Parameters**: 1. Oxalate, 2. Total Volume.**Pretest Condition**: No fasting required; patients should collect complete 24-hour urine.**Specimen**: 10 mL aliquot from 24-hour urine in 1 sterile container, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 24 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on stone episodes, diet, family history.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of undetected hyperoxaluria including recurrent stones, benefits of assessment, and minimal discomfort from collection.**Procedural Considerations**: The test involves sample processing using spectrophotometry by trained personnel to ensure sterile technique and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Incomplete collection, delays beyond stability periods, improper storage conditions, or high-oxalate diet can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Elevated oxalate (>45 mg/24h) indicates hyperoxaluria, necessitating specialist input.**Specialist Consultation**: Urologists or nephrologists should be consulted for management.**Additional Supporting Tests**: Stone analysis, serum oxalate for confirmation.**Test Limitations**: Collection inconvenience; comprehensive approach required.**References**: Indian Journal of Urology 2024, Urolithiasis Studies India 2023. |
